Public Release: 

New research challenges advice that men should abstain from sex before fertility treatment

European Society of Human Reproduction and Embryology

Madrid, Spain: New research by Israeli fertility experts has challenged current medical opinion, which holds that refraining from sex for up to a week at least is beneficial for men prior to undergoing some types of fertility treatment.

Doctors and scientists from Soroka University and Ben-Gurion University of the Negev, Beer-Sheva, tested over 7,200 semen samples for semen volume, sperm concentration and shape, and the percentage and total count of motile (active and moving) sperm. The samples were from around 6,000 men being investigated or treated for infertility who had abstained from sex for periods up to two weeks.

More than 4,500 of the samples had normal sperm counts while the remainder had varying degrees of oligozoospermic (reduced) counts ranging from mild, through moderate, to severe.

The researchers found that while the volume of semen increased up to 11 to 14 days of abstinence, whatever the sperm count was, the morphology (shape and form) of the sperm gradually deteriorated.

In the samples from men with reduced sperm counts the proportion of motile sperm actually fell significantly from day two onwards, reaching a low at day six and remaining low.

Dr. Eliahu Levitas will tell the annual meeting of the European Society of Human Reproduction and Embryology today (Monday 30 June) in Madrid: "Semen volume was directly and significantly correlated with duration of abstinence, while sperm motility was inversely and significantly related to abstinence in oligozoospermic samples only. The percentage of normal forms of sperm was inversely and significantly related to abstinence in both moderately oligozoospermic and normal samples."

Dr. Levitas, a senior physician at the fertility and IVF unit of Soroka University Medical Center, said that most fertility clinics followed the World Health Organisation guidelines of recommending sexual abstinence for two to seven days prior to treatment.

"Our data challenge the role of abstinence in male infertility treatments. What we have found is not so relevant to ICSI, where only a single sperm is injected into the egg, but for those treatments where we are trying to get the best possible sperm quality for intra-uterine insemination.[1]

"For these patients we recommend minimal abstinence - ideally no more than two days."

Dr. Levitas said there was no real consensus among researchers as to why sperm gets damaged and becomes less viable. "It's possible that there is oxidative DNA damage by, for example, cigarette smoking or other damaging agents. Or perhaps the sperm from oligozoospermic men is more susceptible to detrimental agents and therefore might benefit from spending only a short time in the reproductive tract."


Abstract no: O-069 (Monday, 16.15hrs CET, Paris room)


[1] Intra-uterine insemination (IUI): a technique by which a prepared specimen of semen is injected via a cannula through the cervix directly into the uterine cavity. It is useful for women with deficient cervical mucus and is widely used for unexplained infertility and mild endometriosis before resorting to IVF. The frequency of IUI use varies between fertility clinics. In the Fertility and IVF Unit at Beer-Sheva, most women whose partner has a mild or moderately reduced sperm count or where the couple has unexplained fertility will undergo IUI as a first step, and about half become pregnant by this method.

Further information:
Margaret Willson, information officer
Tel: +44-0-153-677-2181
Fax: +44-0-153-677-2191
Mobile: +44-0-797-385-3347

Emma Mason, information officer
Tel: +44-0-137-656-3090
Fax: +44-0-137-656-3272
Mobile: +44-0-771-129-6986

Press Office: (Sunday 29 June -Wednesday 2 July)
Margaret Willson, Emma Mason, Maria Maneiro, Janet Blümli
Tel: + 34-91-722-0501 or +34-91-722-0502
Fax: +34-91-722-0503

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.